These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3499967)

  • 1. The use of the MPTP-treated mouse as an animal model of parkinsonism.
    Heikkila RE; Sonsalla PK
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):436-40. PubMed ID: 3499967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE; Hess A; Duvoisin RC
    Life Sci; 1985 Jan; 36(3):231-6. PubMed ID: 3917525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA; Walters AS; Heikkila RE
    Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.
    Sonsalla PK; Heikkila RE
    Eur J Pharmacol; 1986 Oct; 129(3):339-45. PubMed ID: 3490988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.
    Arai N; Misugi K; Goshima Y; Misu Y
    Brain Res; 1990 May; 515(1-2):57-63. PubMed ID: 2357577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS; de Vries J; Hazelhoff B; Horn AS
    J Med Chem; 1986 Mar; 29(3):424-7. PubMed ID: 3485197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.
    Heikkila RE; Hess A; Duvoisin RC
    Science; 1984 Jun; 224(4656):1451-3. PubMed ID: 6610213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
    Ferraro TN; Golden GT; DeMattei M; Hare TA; Fariello RG
    Neuropharmacology; 1986 Sep; 25(9):1071-4. PubMed ID: 2430229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice.
    Youngster SK; Duvoisin RC; Hess A; Sonsalla PK; Kindt MV; Heikkila RE
    Eur J Pharmacol; 1986 Mar; 122(2):283-7. PubMed ID: 3486770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
    Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
    Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Saitoh T
    J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.